Long-term use of benzodiazepines in chronic insomnia: a European perspective
Authors:
Top Cited Papers
Open Access
- 2 August 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14, 1212028
Abstract
Chronic insomnia occurs in ~10% of the general population and has numerous negative health effects. The recommended first line treatment of cognitive behavior therapy for insomnia is not widely available for patients in Europe, so pharmacotherapies such as benzodiazepine receptor agonist agents (benzodiazepines and Z-drugs) are commonly used. However, their use is only recommended for ≤4 weeks due to unproven long-term efficacy in treatment of chronic insomnia, and the risk of tolerance, and the potential for dependence and misuse. In Europe, recommendations limiting the use of benzodiazepines (lowest dose and shortest duration) in chronic insomnia are not always followed, likely due to the lack of approved effective alternative therapies. Here we present a recent pilot survey of the pharmacological treatment landscape in chronic insomnia in five European countries (France, Germany, Italy, Spain, and the United Kingdom) and physicians’ attitude toward treatment. The results suggest that benzodiazepines and Z-drugs are the most widely used treatments in chronic insomnia and are being used for longer than their recommended duration. Country variations in prescription rates were observed. Due to the known association between long-term benzodiazepine use and potential for developing dependence, further analysis of the literature was performed on the use and misuse of benzodiazepines. The results show that long-term use of benzodiazepines is associated with multiple consequences of treatment, including dependence, but also that previous use of benzodiazepines may increase the risk of opioid use disorder.Keywords
This publication has 120 references indexed in Scilit:
- Lormetazepam addiction: data analysis from an Italian medical unit for addictionRisk Management and Healthcare Policy, 2012
- Benzodiazepines revisited—will we ever learn?Addiction, 2011
- Chronic Insomnia: Clinical and Research Challenges - An AgendaPharmacopsychiatry, 2010
- Benzodiazepines Predict Use of Opioids—A Follow-Up Study of 17,074 Men and WomenPain Medicine, 2010
- Predictors of the incidence and discontinuation of long-term use of benzodiazepines: A population-based studyDrug and Alcohol Dependence, 2009
- Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later—a follow‐up study of 13 390 men and women aged 40–42 yearsPharmacoepidemiology and Drug Safety, 2008
- An international survey of insomnia: under-recognition and under-treatment of a polysymptomatic conditionCurrent Medical Research and Opinion, 2005
- The diagnosis and management of benzodiazepine dependenceCurrent Opinion in Psychiatry, 2005
- Cognitive Effects of Long-Term Benzodiazepine UseCNS Drugs, 2004
- Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?JAMA, 1989